Skip to main content
3 Biotech logoLink to 3 Biotech
. 2019 Aug 19;9(9):338. doi: 10.1007/s13205-019-1866-6

Biofilm formation in marine bacteria and biocidal sensitivity: interplay between a potent antibiofilm compound (AS162) and quorum-sensing autoinducers

Emmanuel Gozoua 1,2, Rose Koffi-Nevry 2, Yves Blache 1,
PMCID: PMC6701715  PMID: 31467830

Abstract

The capacity of two homoserine lactones to stimulate the marine bacteria Pseudoalteromonas ulvae (TC14 strain) for its capacity to form a biofilm when exposed to a potent antibiofilm compound AS162 is reported. Effective concentrations (EC50) of AS162 at 24 h, 48 h, and 72 h were, respectively, of 4.3, 4.4, and 6.0 µM. When tested in combination with HSLs, results showed that quorum-sensing signal molecules 3-oxo-C6 and 3-oxo-C8 homoserine lactones do not act directly on the biofilm formation, but are able to interfere positively with AS162 to promote biofilm growth with EC50 ranging from 30 to 50 µM. The same results were obtained with two other marine bacterial strains: Pseudoalteromonas lipolytica TC8 and Paracoccus sp. 4M6. These findings suggest that HSLs can significantly affect the biocidal sensitivity of marine bacteria to antifouling agents.

Electronic supplementary material

The online version of this article (10.1007/s13205-019-1866-6) contains supplementary material, which is available to authorized users.

Keywords: Quorum sensing, Biofilm, Antimicrobial, Biocontrol

Introduction

In the marine environment, biofouling is defined as a rapid colonization of microorganisms (bacteria, microalgae, etc.) on artificial or natural surfaces causing large and significant economic damages (Yebra et al. 2004; Fitridge et al. 2012; Qian et al. 2007). To prevent such an undesirable process, antifouling coatings have been routinely used to protect the hulls of ships, as well as of smaller vessels. Such coatings are based on the use of broad-spectrum biocides. As their use is now strictly regulated by International Marine organization (IMO), there is a great need of friendly environmentally antifouling solutions which should act specifically on biofouling without killing targeted and non-targeted microbial species (Ciriminna et al. 2015). For this purpose, non-toxic molecules that could have the ability to inhibit the formation of biofilms in a non-permanent way are of major interest in a goal of respect for ecosystems, and a biomimetic approach should offer a practical solution. In this way, the observation of marine organisms such as corals, sponges, or macroalgae which conserve their surfaces free of fouling (Hamann et al. 1993; Steinberg et al. 1997; Müller et al. 2003; Krug 2006) led to the discovery of secondary metabolites possessing antifouling properties (Tsukamoto et al. 1996a, b, c; De Nys and Steinberg 2002; Bhadury and Wright 2004; de Nys and Fusetani 2004; Hellio et al. 2005; Sipkema et al. 2005; Maréchal and Hellio 2009; Fusetani 2011; Gerwick and Moore 2012; Stowe et al. 2011; Sun et al. 2018). However, although effectives, such molecules inhibit irreversibly the formation of biofilms and generally remain still toxic for marine organisms. In this context, there is a great urge for the conception of smart biocides which could exhibit temporary antibiofilm properties allowing their use in an environmentally friendly way without affecting aquatic life. As a part of our studies aimed to the discovery of original compounds able to modulate biofilm formation, we have initiated a program aimed to a biomimetic approach. This program involved the synthesis of analogues of natural products, with the advantage to be non or poorly toxic (Linares et al. 2011; Andjouh and Blache 2015, 2016), and led to the discovery of an original analogue of psammaplin A alkaloid AS162 (Andjouh 2017, 2019) (Fig. 1). To investigate, furthermore, the eco-friendly aspect of such molecule, we report here the potential role of quorum-sensing signal molecules in the biofilm growth of marine bacteria when exposed to this antibiofilm molecule. Quorum sensing (QS) is a signaling pathway present in almost Gram-negative bacteria (Passos da Silva et al. 2017) and is termed as the ability of bacteria to perceive rapidly changes in concentrations of small secreted signalling molecules known as autoinducers (AI-1 and AI-2) (Waters and Bassler 2005). In the marine environment, this pathway of intra- and inter-communication in the bacterial community is of high prevalence and a recent study showed that a large number of marine bacteria can produce autoinducers of type I (homoserine lactones: HSLs) (Muras et al. 2018). In response to these changes, several modifications in the metabolic engine appear, such as biosurfactant production, exopolysaccharide (EPS) production, and biofilm formation. To our knowledge, although QS inhibitors have been largely described to interfere with biofilm formation, no studies showed that QS signal molecules (HSLs) were able to counteract an antibiofilm effect for the restoration of biofilms in bacteria when treated with antibiofilm compounds. For this purpose, we have identified a Mediterranean Sea-isolated strain, Pseudoalteromonas ulvae, TC14 to produce violacein and which possesses a functional QS receptor capable of sensing extrinsic homoserine lactones (HSLs) (Ayé et al. 2015). Among all the HSLs tested, two of them (3-oxo-C6-HSL and 3-oxo-C8-HSL) retained our attention for their capacity to interact with the production of violacein. We now report the capacity of these two HSLs to modulate biofilm production and biocidal susceptibility when the bacteria are submitted to the highly efficient antibiofilm compound AS162 (Fig. 1).

Fig. 1.

Fig. 1

Structure of the antibiofilm compound AS162, and of the two homoserine lactones studied

Results and discussion

Effect of 3-oxo-C6 and 3-oxo-C8-HSLs on biofilm growth of TC 14

Since the exposition to exogenous HSLs was previously reported to affect positively the bacterial growth and biofilm formation of isolated marine bacteria (Pseudomonas genus) (Mangwani et al. 2016), the first point of our study was to check the intrinsic effect of HSLs (3-oxo-C6-HSL and 3-oxo-C8-HSL) on biofilm formation and on bacterial growth of Pseudoalteromonas ulvae TC14 over a period of 72 h. It was reported that none of these two HSLs modified TC14 growth compared to the control sample (without added AHLs) over a short time of 7 h (Ayé et al. 2015), suggesting that they do not present any toxicity on this strain in these conditions. Taking into account these observations and preliminary results, biofilm formation as well as viability of the bacteria were monitored over 72 h for a set of concentrations ranging from 10 to 200 µM. Results at 72 h are reported in Fig. 2 (results at 24 h and 48 h for biofilm growth, bacterial growth over 72 h are reported in Supplementary data, Figs. A1 and A2). In spite of the fact that the regulation of biofilm by quorum sensing has often been described in Gram-negative bacteria, our results suggest that these two HSLs did not affect the biofilm growth after 72 h at low-to-medium concentrations. Furthermore, the viability of the bacterial strains was also found to be not affected when exposed to increasing concentrations of HSLs over the 72 h period. According these results, the concentration of 50 μM was retained for studying the combination.

Fig. 2.

Fig. 2

Left, effect of 6-oxo-HSL (■ 3-oxo-C6) and 3-oxo-C8-HSL (■ 3-oxo-C6) at concentrations of 10–200 μM on biofilm growth of Pseudoalteromonas ulvae TC14 at 72 h. Data are expressed as  % of biofilm when compared to an untreated sample (100%). Right, effect on viability of Pseudoalteromonas ulvae TC14 at 72 h. Data are expressed as  % of viable bacteria when compared to an untreated sample with 100% of viability

Interplay between HSLs and AS162

Although the mode of action of this molecule is not yet elucidated, AS162 is a potent antibiofilm and non-biocidal compound against various marine bacteria strains at low concentrations (EC50 in the range of 5 µM), while at high concentrations (> 100 µM), a biocidal effect was observed decreasing the viability (more than 50% after 7 h) (Andjouh 2017, 2019). Taking into account these results, long-term effect of AS162 and the potential role of HSLs to limit biocidal effect over 72 h were investigated by monitoring the viability of the bacterial population. In this way, the effect of AS162 (respectively, at 10, 25, 50, 100, 150, and 200 µM) over 72 h and the effect of its combination with 3-oxo-C6-HSL and 3-oxo-C8-HSL are reported in Fig. 3. Results showed that AS162 has a long-term effect on viability and that these effects are dose dependent with an LC50 (72 h) of 100 µM (Table 1). The same experiment was conducted with AS162 administrated in combination with 50 µM of the two AHLs. No modification of the toxicity profile was noted, indicating that AHLs do not interact directly with the toxicity pathway of AS162. These results finally are in good agreement with our first report (over 7 h) and confirm the potential long-term antimicrobial effect of AS162 at high concentrations. With these elements in hand, the effect of AS162 in combination with AHLs on biofilm growth was studied over 72 h. Results were unambiguous and showed that the two AHLs were able to limit the antibiofilm effect of AS162 (Fig. 3 and Table 1). More precisely, the initial stage of biofilm at 24 h was greatly impacted at a low concentration of 10 µM of AS162, since the biofilm is recovered to more than 80% when compared to untreated sample. The same observation was made at 48 and 72 h. Taking in account that at this concentration, only 80% of cells are viable, we can consider that biofilm is recovered at 100% of viable bacteria. When the sample was treated with higher concentrations of AS162 (> 50 µM), we can remark that restoration is lower, but this result is not surprising, since the capacity to form a biofilm is directly connected with the number of viable bacteria [for example, LC50 (72 h) = 100 µM and  % of biofilm (72 h) at this concentration are only of 50% when compared to untreated sample and these finally correspond to 100% of viable cells).

Fig. 3.

Fig. 3

Effect of combinations on viability of Pseudoalteromonas ulvae TC14, data are expressed as percentage of viable bacteria when compared to untreated sample (100%) (up, left). Effect of combinations on the biofilm growth of Pseudoalteromonas ulvae TC14 at 24 h (up, right), 48 h (down, left), and 72 h (down, right). Data are expressed as percentage of biofilm when compared to untreated sample (100%) (*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001)

Table 1.

Biological screening of compound AS162 and its combination with 3-oxo-C6-HSL and 3-oxo-C8-HSL

Compounds Antibiofilm activity: EC50 (μM) Toxicity: LC50 at 72 h
24 h 48 h 72 h
Pseudoalteromonas ulvae TC14
 AS162 4.3 ± 1.0 4.4 ± 1.2 6.0 ± 1.4 100.1 ± 25.9
 AS162 + 3-oxo-C6 (50 µM) 64.2 ± 5.7 20.0 ± 3.4 50.9 ± 4.7 97.9 ± 18.7
 AS162 + 3oxo-C8 (50 µM) 62.9 ± 8.7 23.0 ± 4.7 55.0 ± 3.4 105.0 ± 1.96
Pseudoalteromonas lipolytica TC8
 AS162 23.2 ± 2.4 29.3 ± 4.0 36.5 ± 2.8 96.5 ± 12.3
 AS162 + 3-oxo-C6 (50 µM) 50.8 ± 2.8 37.1 ± 2.7 38.0 ± 7.0 105.7 ± 28.5
 AS162 + 3oxo-C8 (50 µM) 52.9 ± 4.7 46.7 ± 1.7 45.2 ± 1.7 105.6 ± 11.5
Paracoccus sp. 4M6
 AS162 8.0 ± 0.8 18.8 ± 2.1 25.9 ± 2.4 78.4 ± 1 2.4
 AS162 + 3-oxo-C6 (50 µM) 41.1 ± 1.8 47.8 ± 2.4 44.6 ± 2.6 92.4 ± 4.1
 AS162 + 3oxo-C8 (50 µM) 35.2 ± 2.4 53.3 ± 1.4 47.0 ± 3.8 95.5 ± 3.2

Left: antibiofilm activity against bacterial biofilms of Pseudoalteromonas ulvae (TC14). Pseudoalteromonas lipolytica (TC8), Paracoccus sp. (4M6). Results are expressed as effective concentration to inhibit 50% of biofilm formation (EC50) in micromoles/L (µM). Right: toxicity of compound AS162 and its combination with 3-oxo-C6-HSL and 3-oxo-C8-HSL against TC14, TC8, 4M6. Results are expressed as the concentration which causes the death of 50% of the bacterial population (lethal concentration, LC50) in micromoles/L (µM). Data represent means ± standard deviations values from three independent experiments

Taken together, our results indicated that the QS regulation pathway is not directly implicated in biofilm formation of TC14, but indirectly, the two AHLs tested are able to interfere with biofilm growth when the bacteria are treated with an effective antibiofilm compound. This highlights a crucial role of QS in the remediation pathway of this marine strain to bypass the effect of antibiofilm compounds. In addition, these experiments were also extended to two additional strains of marine bacteria responsible of micro-fouling (Pseudoalteromonas Lipolytica TC8 and Paracoccus sp. 4M6 strains). All the results are reported in Table 1 and Supplementary data (Figs. A3–A7). In a similar manner, it was interesting to note that AHLs did not impact biofilm formation no more than bacterial growth and viability of these two strains, and the resulting EC50 of the combinations highlight analogous results, especially at 24 h.

In summary, we have shown that marine bacterial biofilms are able of being positively responsive to exogenous HSLs when submitted to environmental changes such as exposure to antibiofilm molecules. HSLs were observed to promote the biofilm growth of the three strains when exposed to efficient concentrations of the antibiofilm compound AS162. This suggests that in bacterial communities, the interplay with quorum-sensing autoinducers appears of primary importance to maintain the capacity to form biofilms by modulating the efficiency of non-biocidal antibiofilm compounds. In addition, such results should to be taken in account as specific bioassays for assessing a reversible or permanent efficiency of antibiofilm compounds in the course for designing eco-friendly antibiofilm solutions.

Materials and methods

Bacterial strains

Three marine Gram-negative bacterial strains Pseudoalteromonas ulvae (TC14), Pseudoalteromonas lipolytica (TC8), and Paracoccus sp. (4M6) were used in the study (Brian-Jaisson et al. 2014). TC14 was isolated in June 2010 in Little Bay of Toulon (1 m depth, Mediterranean Sea, France) (Brian-Jaisson et al. 2014). The strain 4M6 was provided by the LBCM (Université de Bretagne Sud). It was isolated on glass slides immersed during 6 h at 1 m depth in March 2000 in the Morbihan Gulf (Bailleron Island, 47_3403700 N-2_4405400 W, Atlantic Ocean) (Grasland et al. 2003). TC8 was isolated in February 2008 in Little Bay of Toulon y (1 m depth, Mediterranean Sea, France) (Camps et al. 2011).

Antibiofilm bioassay at 24 h (adhesion bioassays) (Camps et al. 2011; Othmani et al. 2014)

Bacterial strains were grown on Väätänen nine-salts solution (VNSS). When the stationary phase was reached, bacterial suspension was centrifuged. Cells were then diluted in sterile artificial sea water (ASW) and introduced into microtiter plates (sterile black PS; Nunc, Fisher Scientific, France) with tested molecules at eight concentrations (2, 5, 10, 20, 50, 100, 150, and 200 µM) in three replicates in the presence of controls: (i) non-specific staining control and (ii) adhesion control. The maximum percentage of solvent (final concentration = DMSO 2%) used for the dilution of biocides was also tested in triplicate as additional control to insure the non-effect of solvent. After incubation during 24 h, the non-adhered bacteria were eliminated and the adhered cells were quantified after SYTO® 61 (Molecular Probes®Invitrogen, France) (1 µM) staining. A percent of inhibition was calculated per well:

MeanFIi-nsCiMeanFIc-MeanB×100

with FIi as the fluorescence intensity in a treated well (tested compound + bacteria + SYTO® 61), FIc as the fluorescence intensity in a control well (bacteria + SYTO® 61), nsCi as the non-specific control (tested compound without bacteria + SYTO® 61), and B as the blank, i.e., stain control (only SYTO® 61). A sigmoid dose–response curve was obtained when plotted the percentage of inhibition with the log of compound concentrations, after mean (n = 3) and standard deviation (SD) calculation per triplicate for each concentration. EC50 values were then calculated for each compound using GraphPad Prism® (GraphPad Software, USA). This software allowed also to perform statistical tests dedicated to the analysis of two variables simultaneously, such as the difference between strains and between biocides (two-way ANOVA). Significant differences were accepted when p < 0.05 (*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001).

Antibiofilm bioassays at 48 h and 72 h

The evolution of biofilm formation was analyzed using the Crystal Violet (CV) assay following the protocol of Liu et al. (2012) with some modifications. Post-exponential phase Pseudoalteromonas ulvae (TC4), Pseudoalteromonas lipolytica (TC8), and Paracoccus sp. (4M6) subcultures in ASW were centrifuged and resuspended in ASW to reach an OD600 of 0.4. The bacterial suspension was then inoculated in 96-well microplates with or without the addition of AS162 and/or AHLs at the corresponding concentrations. After 48 h of incubation at 20 °C under humid conditions, the planktonic cells and media were removed, and the bacteria were washed twice with 100 μL of a solution of sodium chloride (36 g/L) to remove the remaining non-adherent bacteria. The cells were then fixed at a temperature of 50 °C for 30 min. Biofilm was marked with 200 μL of 0.01% (w/v) CV in distilled water for 15 min. Microplates wells were then washed three times with 200 μL of distilled water, followed by a 15 min drying time at room temperature. To release the CV adsorbed by the biofilm cells, a solubilization step was performed by the addition of 100 μL of absolute ethanol per well followed with an agitation of 5 min at 120 rpm. Then, the solution containing ethanol and solubilized CV was transferred from the microplate into another sterile 96-well microplate and the OD of each well was measured at 570 nm (OD570) using a Tecan microplate reader. The data are reported as the CV absorbance at 570 nm of bacterial samples subtracted from CV absorbance of the sterile media containing AS162 and/or AHLs and divided by CV absorbance of the sterile media which were used as controls into a microplate and treated in the same manner as wells containing bacteria.

Toxicity tests: (Camps et al. 2011; Othmani et al. 2014)

After growth on VNSS, bacterial strains were picked up during the exponential phase. The microtiter plates (sterile transparent PS) were filled as described in the protocol of the antiadhesion assay but using VNSS instead of ASW to allow bacterial growth. The bacterial growth was followed by measuring the turbidity (OD600 nm) during 72 h. Then, resazurin (50 μM) was added in all the wells, and fluorescence was measured after 2 h to quantify the percent of bacterial viability. The same methodology used with SYTO® 61 was applied to calculate a percent of viability after resazurin staining. Only compounds with EC50 lower than 200 μM were tested and experiments were performed at a concentration of 100 µM of each compound (AS 162 and combinations) with an untreated sample as a reference.

Statistical tests and calculations of EC50 and LC50

EC50 and LC50 values were calculated for each compound using GraphPad Prism® (GraphPad Software, USA). This software allowed also to perform statistical tests dedicated to the analysis of two variables simultaneously, such as the difference between strains and between compounds (two-way ANOVA). Significant differences were accepted when p ≤ 0.05 (*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001).

Electronic supplementary material

Below is the link to the electronic supplementary material.

Acknowledgements

This research did not receive any specific grant from funding agencies (public, or private). The Paracoccus sp. strain 4M6 was provided by the LBCM (Université de Bretagne Sud).

Compliance with ethical standards

Conflict of interest

No conflict of interest declared.

References

  1. Andjouh S, Blache Y. Click-based synthesis of bromotyrosine alkaloid analogs as potential anti-biofilm leads for SAR studies. Bioorg Med Chem Lett. 2015;25(24):5762–5766. doi: 10.1016/j.bmcl.2015.10.073. [DOI] [PubMed] [Google Scholar]
  2. Andjouh S, Blache Y. Screening of bromotyramine analogues as antifouling compounds against marine bacteria. Biofouling. 2016;32(8):871–881. doi: 10.1080/08927014.2016.1200562. [DOI] [PubMed] [Google Scholar]
  3. Andjouh S, Blache Y. Parallel synthesis of a bis-triazoles library as psammaplin A analogues: a new wave of antibiofilm compounds? Bioorg Med Chem Lett. 2019 doi: 10.1016/j.bmcl.2018.12.047. [DOI] [PubMed] [Google Scholar]
  4. Andjouh S, Perrin FX, Blache Y (2017) in “bis-triazoles compounds with anti-biofilm and anti-corrosion properties”. WO 2017/102883 A1, International Application Number PCT/EP2016/081068. US 2018 / 0370953 A1. https://patents.google.com/patent/US20180370953A1/en
  5. Ayé AM, Bonnin-Jusserand M, Brian-Jaisson F, Ortalo-Magné A, Culioli G, Nevry RK, Blache NY, Molmeret M. Modulation of violacein production and phenotypes associated with biofilm by exogenous quorum sensing N-acylhomoserine lactones in the marine bacterium Pseudoalteromonas ulvae TC14. Microbiology. 2015;161(10):2039–2051. doi: 10.1099/mic.0.000147. [DOI] [PubMed] [Google Scholar]
  6. Bhadury P, Wright P. Exploitation of marine algae: biogenic compounds for potential antifouling applications. Planta. 2004;219:561–578. doi: 10.1007/s00425-004-1307-5. [DOI] [PubMed] [Google Scholar]
  7. Brian-Jaisson F, Ortalo-Magné A, Guentas-Dombrowsky L, Armougom F, Blache Y, Molmeret M. Identification of bacterial strains isolated from the mediterranean sea exhibiting different abilities of biofilm formation. Microb Ecol. 2014;68:94–110. doi: 10.1007/s00248-013-0342-9. [DOI] [PubMed] [Google Scholar]
  8. Camps M, Briand J-F, Guentas-Dombrowsky L, Culioli G, Bazire A, Blache Y. Antifouling activity of commercial biocides vs. Natural and natural-derived products assessed by marine bacteria adhesion bioassay. Mar Poll Bull. 2011;62:1032–1040. doi: 10.1016/j.marpolbul.2011.02.031. [DOI] [PubMed] [Google Scholar]
  9. Ciriminna R, Bright F, Pagliaro M. Ecofriendly antifouling marine coatings. ACS Sustain Chem Eng. 2015;3:559–565. doi: 10.1021/sc500845n. [DOI] [Google Scholar]
  10. De Nys R, Steinberg PD. Linking marine biology and biotechnology. Curr Opin Biotechnol. 2002;13:244–248. doi: 10.1016/S0958-1669(02)00311-7. [DOI] [PubMed] [Google Scholar]
  11. Fitridge I, DempsterT Guenther J, de Nys R. The impact and control of biofouling in marine aquaculture: a review. Biofouling. 2012;28:649–669. doi: 10.1080/08927014.2012.700478. [DOI] [PubMed] [Google Scholar]
  12. Fusetani N. Biofouling and antifouling. Nat Prod Rep. 2004;21:94–104. doi: 10.1039/b302231p. [DOI] [PubMed] [Google Scholar]
  13. Fusetani N. Antifouling marine natural products. Nat Prod Rep. 2011;28:400–410. doi: 10.1039/C0NP00034E. [DOI] [PubMed] [Google Scholar]
  14. Gerwick WH, Moore Bradley S. Lessons from the past and charting the future of marine natural products drug discovery and chemical biology. Chem Biol. 2012;19:85–98. doi: 10.1016/j.chembiol.2011.12.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Grasland B, Mitalane J, Briandet R, Quémener E, Meylheuc T, Linossier I, Vallée-Réhel K, Haras D. Bacterial biofilm in seawater: cell surface properties of early-attached marine bacteria. Biofouling. 2003;19:307–331. doi: 10.1080/0892701031000121041. [DOI] [PubMed] [Google Scholar]
  16. Hamann MT, Scheuer PJ, Kelly-Borges M. Biogenetically diverse, bioactive constituents of a sponge, order verongida: bromotyramines and sesquiterpene-shikimate derived metabolites. J Org Chem. 1993;58:6565–6569. doi: 10.1021/jo00076a012. [DOI] [Google Scholar]
  17. Hellio C, Tsoukatou M, Maréchal J-P, Aldred N, Beaupoil C, Clare AS, Vagias C, Roussis V. Inhibitory effects of mediterranean sponge extracts and metabolites on larval settlement of the barnacle balanus amphitrite. Mar Biotechnol. 2005;7:297–305. doi: 10.1007/s10126-004-3150-x. [DOI] [PubMed] [Google Scholar]
  18. Krug PJ. Antifouling compounds. Berlin, Heidelberg: Springer; 2006. Defense of benthic invertebrates against surface colonization by larvae: a chemical arms race; pp. 1–53. [DOI] [PubMed] [Google Scholar]
  19. Linares D, Bottzeck O, Pereira O, Praud-Tabariès A, Blache Y. Designing 2-aminoimidazole alkaloids analogs with anti-biofilm activities: structure–activities relationships of polysubstituted triazoles. Bioorg Med Chem Lett. 2011;21:6751. doi: 10.1016/j.bmcl.2011.09.050. [DOI] [PubMed] [Google Scholar]
  20. Liu N, Xu Y, Hossain S, Huang N, Coursolle D, Gralnick JA, Boon EM. Nitric oxide regulation of cyclic di-GMP synthesis and hydrolysis in Shewanella woodyi. Biochem. (Mosc) 2012;51:2087–2099. doi: 10.1021/bi201753f. [DOI] [PubMed] [Google Scholar]
  21. Mangwani N, Kumari S, Das S. Effect of synthetic N-acylhomoserine lactones on cell–cell interactions in marine Pseudomonas and biofilm mediated degradation of polycyclic aromatic hydrocarbons. Chem Eng J. 2016;302:172–186. doi: 10.1016/j.cej.2016.05.042. [DOI] [Google Scholar]
  22. Maréchal J-P, Hellio C. Challenges for the development of new non-toxic antifouling solutions. Int JMol Sci. 2009;10:4623–4637. doi: 10.3390/ijms10114623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Müller WG, Brümmer F, Batel R, Müller I, Schröder H. Molecular biodiversity. Case study: Porifera (sponges) Naturwissenschaften. 2003;90:103–120. doi: 10.1007/s00114-003-0461-0. [DOI] [PubMed] [Google Scholar]
  24. Muras A, López-Pérez M, Mayer C, Parga A, Amaro-Blanco J Ana, Otero A. High prevalence of quorum-sensing and quorum-quenching activity among cultivable bacteria and metagenomic sequences in the mediterranean sea. Genes. 2018;9:100. doi: 10.3390/genes9020100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Othmani A, Bouzidi N, Viano Y, Alliche Z, Seridi H, Blache Y, El Hattab M, Briand J-F, Culioli G. Anti-microfouling properties of compounds isolated from several mediterranean dictyota spp. J Appl Phycol. 2014;26:1573–1584. [Google Scholar]
  26. Passos da Silva D, Schofield MC, Parsek MR, Tseng BS. An update on the sociomicrobiology of quorum sensing in gram-negative biofilm development. Pathogens (Basel Switz.) 2017;6:51. doi: 10.3390/pathogens6040051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Qian PY, Lau SCK, Dahms HU, Dobretsov S, Harder T. Marine biofilms as mediators of colonization by marine macroorganisms: implications for antifouling and aquaculture. Mar Biotechnol. 2007;9:399–410. doi: 10.1007/s10126-007-9001-9. [DOI] [PubMed] [Google Scholar]
  28. Sipkema D, Franssen MR, Osinga R, Tramper J, Wijffels R. Marine sponges as pharmacy. Mar Biotechnol. 2005;7:142–162. doi: 10.1007/s10126-004-0405-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Steinberg P, Schneider R, Kjelleberg S. Chemical defenses of seaweeds against microbial colonization. Biodegradation. 1997;8:211–220. doi: 10.1023/A:1008236901790. [DOI] [Google Scholar]
  30. Stowe SD, Richards JJ, Tucker AT, Thompson R, Melander C, Cavanagh J. Anti-biofilm compounds derived from marine sponges. Mar Drugs. 2011;9:2010–2035. doi: 10.3390/md9102010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sun J, Wu L, An B, de Voogd J, Cheng N, Lin W. Bromopyrrole alkaloids with the inhibitory effects against the biofilm formation of gram-negative bacteria. Mar drugs. 2018;16:9. doi: 10.3390/md16010009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Tsukamoto S, Kato H, Hirota H, Fusetani N. Ceratinamides a and b: new antifouling dibromotyrosine derivatives from the marine sponge pseudoceratina purpurea. Tetrahedron. 1996;52:8181–8186. doi: 10.1016/0040-4020(96)00387-0. [DOI] [PubMed] [Google Scholar]
  33. Tsukamoto S, Kato H, Hirota H, Fusetani N. Ceratinamine: an unprecedented antifouling cyanoformamide from the marine sponge Pseudoceratina purpurea. J Org Chem. 1996;61:2936–2937. doi: 10.1021/jo9602884. [DOI] [PubMed] [Google Scholar]
  34. Tsukamoto S, Kato H, Hirota H, Fusetani N. Pseudoceratidine: a new antifouling spermidine derivative from the marine sponge Pseudoceratina purpurea. Tetrahedron Lett. 1996;37:1439–1440. doi: 10.1016/0040-4039(96)00025-1. [DOI] [Google Scholar]
  35. Waters CM, Bassler BL. Quorum sensing: cell-to-cell communication in bacteria. Annu Rev Cell Dev Biol. 2005;21:319–346. doi: 10.1146/annurev.cellbio.21.012704.131001. [DOI] [PubMed] [Google Scholar]
  36. Yebra DM, Kiil S, Dam-Johansen K. Antifouling technology past, present and future steps towards efficient and environmentally friendly antifouling coatings. Prog Org Coat. 2004;50:75–104. doi: 10.1016/j.porgcoat.2003.06.001. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from 3 Biotech are provided here courtesy of Springer

RESOURCES